Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT

Robin, M. orcid.org/0000-0003-1388-9876, Iacobelli, S., Koster, L. et al. (22 more authors) (2024) Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, 59 (7). pp. 928-935. ISSN 0268-3369

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 The Author(s), under exclusive licence to Springer Nature Limited.

Keywords: Cancer immunotherapy; Diseases; Stem-cell research
Dates:
  • Published: July 2024
  • Published (online): 15 March 2024
  • Accepted: 7 March 2024
  • Submitted: 7 November 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 03 Apr 2024 13:30
Last Modified: 15 Nov 2024 12:05
Status: Published
Publisher: Springer Science and Business Media LLC
Refereed: Yes
Identification Number: 10.1038/s41409-024-02269-4
Related URLs:
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics